Inhibikase Therapeutics
IKT
IKT
9 hedge funds and large institutions have $975K invested in Inhibikase Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$107K |
2 |
HF
2
HRT Financial
New York
|
$69K |
3 |
3
Millennium Management
New York
|
$67K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$3K |
5 |
5
BlackRock
New York
|
$3K |